How long after dengue infection do Immunoglobulin M (IgM) and Immunoglobulin G (IgG) antibodies become detectable in an antigen test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of IgM and IgG Antibodies in Dengue Infection

IgM antibodies typically appear 3-5 days after symptom onset, while IgG antibodies develop around day 5-7 in primary infections and earlier in secondary infections. 1, 2

Antibody Development Timeline

IgM Antibodies

  • IgM antibodies become detectable during the first week of illness, typically appearing by day 3-5 after symptom onset 1, 2
  • By day 8 of illness, nearly 100% of patients will have detectable IgM antibodies 2
  • IgM levels peak approximately 2 weeks after symptom onset 3
  • IgM antibodies remain detectable for 2-3 months after infection before declining to undetectable levels 1, 3

IgG Antibodies

  • In primary infections, IgG antibodies typically appear around day 5-7 after symptom onset, initially at low levels 2, 4
  • IgG levels increase more slowly than IgM in primary infections, reaching peak levels between days 22-30 4
  • In secondary infections, IgG antibodies appear more rapidly and at higher levels, often detectable from the first few days of illness 3
  • IgG antibodies persist for months to years after infection 1

Diagnostic Considerations

Primary vs. Secondary Infections

  • Primary dengue infections are characterized by a high molar fraction of anti-dengue IgM and low molar fraction of IgG 3
  • Secondary dengue infections show a rapid increase in IgG antibodies with lower levels of IgM antibodies 3
  • The IgG3 subclass appears within the first week, peaks at weeks 2-3, and disappears within 4-6 months (mean duration 149 days), making it a potential biomarker for recent infection 5

Optimal Testing Strategy

  • For specimens collected ≤7 days after symptom onset, nucleic acid amplification tests (NAATs) and NS1 antigen detection are most sensitive 1
  • For specimens collected >7 days after symptom onset, IgM antibody testing becomes more sensitive than molecular methods 1, 6
  • A combination of NS1 antigen and IgM antibody testing provides the highest diagnostic yield (96.9-100%) for samples taken after day 3 of illness 2

Common Pitfalls

  • A negative IgM test during the first few days of illness does not rule out dengue infection, as antibodies may not have developed yet 1
  • IgM and IgG antibodies can cross-react with other flaviviruses, potentially causing false-positive results 1
  • For definitive diagnosis in areas with multiple circulating flaviviruses, confirmatory plaque reduction neutralization tests (PRNTs) may be required 1
  • IgM antibodies may be dramatically lower in secondary dengue infections, potentially leading to false-negative results 3

Testing Algorithm

  1. For patients presenting within 7 days of symptom onset:

    • Perform NAAT and/or NS1 antigen testing as first-line tests 1, 7
    • Consider adding IgM testing if presenting after day 3 2
  2. For patients presenting >7 days after symptom onset:

    • IgM antibody testing is the preferred diagnostic method 1
    • Consider IgG testing to distinguish between primary and secondary infections 3
  3. For indeterminate results or when definitive diagnosis is needed:

    • Perform confirmatory PRNTs against dengue and other endemic flaviviruses 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

LABORATORY DIAGNOSIS OF DENGUE VIRUS INFECTIONS.

The Southeast Asian journal of tropical medicine and public health, 2015

Research

Enzyme immunoassay for the detection of dengue IgG and IgM antibodies using infected mosquito cells as antigen.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1989

Guideline

NS1 Dengue Test Positivity Timeline After Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.